OQROSign up free
Insider trade

Biodesix (BDSX): Director exercised options on 1,360 shares

John Patience, Director at Biodesix, reported an option exercise of 1,360 shares.

1,360
Shares
Traded
Sep 30, 2026
Filed
Oct 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. Oct 1, 2026Federal contract · $8K obligatedDepartment of Veterans Affairs awarded BIODESIX INC: $7.5K obligated to date
  2. Oct 1, 2026Federal contract · $391K obligatedDepartment of Veterans Affairs awarded BIODESIX INC: $391K obligated to date
  3. Nov 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 2, 2026, it was agreed that the employment of Kieran O’Kane, Chief Commercial Officer of Biodesix, Inc. (the “Company”) would end effective November 2, 2026 (the “Separation Date”).”
  4. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 10, 2026Insider · First insider buy since Sep 202510% owner purchased ~$1M of BDSX shares in the open market
  6. Nov 12, 20265% stakeSCHULER JACK W filed an activist stake (13D) of 22.3%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biodesix

For Biodesix, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDSX page.

Other recent filings by John Patience, Director

The full history of John Patience, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Biodesix

Everything OQRO holds on this company is on its BDSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data